Physician profile
Robin L Jack
NPI 1649309394
$1,595.15
in general payments reported to CMS, 2019-2025
17 companies · $392 in 2025
The $392 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $65.86 · 2021: $68.81 · 2022: $200 · 2023: $119 · 2024: $532 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $294.93 | 2023-2025 | Valtoco |
| Ucb, INC. | $206.05 | 2020-2025 | Nayzilam, Briviact, Fintepla |
| Greenwich Biosciences, INC. | $185.91 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $181.68 | 2024-2025 | |
| Ptc Therapeutics, INC. | $125.00 | 2022 | |
| Upsher-Smith Laboratories LLC | $103.68 | 2023-2024 | |
| Acadia Pharmaceuticals INC | $89.67 | 2023-2025 | Daybue |
| Supernus Pharmaceuticals, INC. | $69.89 | 2019-2020 | |
| Sk Life Science, INC. | $60.59 | 2024 | |
| Eisai INC. | $50.26 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $43.06 | 2024-2025 | Zonisade |
| Biocodex, INC. | $42.94 | 2024 | |
| Aquestive Therapeutics, INC. | $41.46 | 2021 | |
| Livanova USA, INC. | $37.32 | 2021-2022 | |
| Immedica Pharma US, INC. | $24.00 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Pharmaceuticals, INC. | $23.97 | 2025 | |
| Travere Therapeutics, INC. | $14.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Jack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.